Glen Leighton

Glenn is the founder of Hydrophis Gas which is developing new chemistry to capture marine CO2 and convert it into bicarbonate powder through biomimicry. He is Chairman of Hutano Diagnostics, making aptamer-based rapid tests for viral illnesses such as Covid-19. Formerly an investment banker, he has over 23 years’ experience of growing businesses through raising debt and equity, corporate (re)structuring and regulatory advisory. He has a PhD from Oxford where he was a Rhodes Scholar in the 1990s, and undergraduate law degrees from universities in Japan and Australia.